StockData
Bruker Corp logo

Bruker Corp (BRKRP) stock

BRKRPNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31Also trades as BRKR
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30308% above fair value
$457.73+12.62 (+2.84%)

Close on Nov 18, 2026Market cap $9.81BP/E –Yield –

Bruker revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Bruker's revenue for the twelve months ending Jun 30, 2026 was $3.50B, up 1.6% year over year. For fiscal 2025 it was $3.44B, up 2.1% from the year before. Over ten years it grew 7.8% a year on average. The highest annual figure on record is $3.44B in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$3.44B+2.1%
FY2024Dec 31, 2024$3.37B+13.6%
FY2023Dec 31, 2023$2.96B+17.1%
FY2022Dec 31, 2022$2.53B+4.7%
FY2021Dec 31, 2021$2.42B+21.7%
FY2020Dec 31, 2020$1.99B-4.1%
FY2019Dec 31, 2019$2.07B+9.3%
FY2018Dec 31, 2018$1.90B+7.3%
FY2017Dec 31, 2017$1.77B+9.6%
FY2016Dec 31, 2016$1.61B-0.8%
FY2015Dec 31, 2015$1.62B-10.2%
FY2014Dec 31, 2014$1.81B-1.7%
FY2013Dec 31, 2013$1.84B+2.7%
FY2012Dec 31, 2012$1.79B+8.5%
FY2011Dec 31, 2011$1.65B+26.6%
FY2010Dec 31, 2010$1.30B+17.1%
FY2009Dec 31, 2009$1.11B–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$838.50M+5.2%
Q1 FY2026Mar 31, 2026$823.40M+2.7%
Q4 FY2025Dec 31, 2025$977.20M-0.2%
Q3 FY2025Sep 30, 2025$860.50M-0.5%
Q2 FY2025Jun 30, 2025$797.40M-0.4%
Q1 FY2025Mar 31, 2025$801.40M+11.0%
Q4 FY2024Dec 31, 2024$979.60M+14.6%
Q3 FY2024Sep 30, 2024$864.40M+16.4%
Q2 FY2024Jun 30, 2024$800.70M+17.4%
Q1 FY2024Mar 31, 2024$721.70M+5.3%
Q4 FY2023Dec 31, 2023$854.50M+20.6%
Q3 FY2023Sep 30, 2023$742.80M+16.3%
Q2 FY2023Jun 30, 2023$681.90M+15.9%
Q1 FY2023Mar 31, 2023$685.30M+15.2%
Q4 FY2022Dec 31, 2022$708.40M+3.6%
Q3 FY2022Sep 30, 2022$638.90M+4.9%
Q2 FY2022Jun 30, 2022$588.40M+3.1%
Q1 FY2022Mar 31, 2022$595.00M+7.3%
Q4 FY2021Dec 31, 2021$683.50M+8.9%
Q3 FY2021Sep 30, 2021$608.90M+19.1%
Q2 FY2021Jun 30, 2021$570.80M+34.4%
Q1 FY2021Mar 31, 2021$554.70M+30.8%
Q4 FY2020Dec 31, 2020$627.50M+4.6%
Q3 FY2020Sep 30, 2020$511.40M-1.9%
Q2 FY2020Jun 30, 2020$424.60M-13.4%
Q1 FY2020Mar 31, 2020$424.00M-8.1%
Q4 FY2019Dec 31, 2019$599.90M+8.4%
Q3 FY2019Sep 30, 2019$521.10M+11.7%
Q2 FY2019Jun 30, 2019$490.20M+10.5%
Q1 FY2019Mar 31, 2019$461.40M+6.9%
Q4 FY2018Dec 31, 2018$553.60M+4.4%
Q3 FY2018Sep 30, 2018$466.60M+7.1%
Q2 FY2018Jun 30, 2018$443.70M+6.9%
Q1 FY2018Mar 31, 2018$431.70M+12.2%
Q4 FY2017Dec 31, 2017$530.50M+12.8%
Q3 FY2017Sep 30, 2017$435.60M+10.6%
Q2 FY2017Jun 30, 2017$414.90M–
Q1 FY2017Mar 31, 2017$384.90M–
Q4 FY2016Dec 31, 2016$470.30M–
Q3 FY2016Sep 30, 2016$393.90M–

More Bruker figures

See a number that looks wrong?